Cipla
Deepak Viegas is an accomplished professional with extensive experience in internal audit and risk management. Currently serving as the Global Head of Internal Audit & Risk Management at Cipla since February 2017, Deepak previously held the position of Director - Risk Consulting at KPMG India from December 2010 to February 2017, where responsibilities included leading Board Governance Services and training Board members on corporate governance. Prior to KPMG, Deepak was Associate Director in Risk Advisory Services at EY, managing sector leadership roles for Life Sciences and Automotive in regions West and North, and building client relationships within BSE 300 companies. Additional experience includes a Senior Manager role at Axis Risk Consulting Services, handling project management and client servicing, an Assistant Manager position at Plus Channel India focusing on cost control, and a Senior role at Sharp & Tannan Associates conducting internal and management audits. Educational credentials comprise a Certified Internal Auditor designation, a Bachelor's Degree in Costing and Financial Management, and a Bachelor's Degree in Accounting from recognized institutions.
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.